Key points are not available for this paper at this time.
A multicountry randomized controlled trial has demonstrated that pan-susceptible pulmonary tuberculosis (TB) can be successfully treated with a 4-month regimen of daily isoniazid, rifapentine, moxifloxacin, and pyrazinamide (HPMZ). We piloted HPMZ in San Francisco (SF) using a modified version of the US Centers for Disease Control and Prevention HPMZ treatment guidelines.
Building similarity graph...
Analyzing shared references across papers
Loading...
Louie et al. (Tue,) studied this question.
www.synapsesocial.com/papers/68e7242fb6db64358769dd5a — DOI: https://doi.org/10.1093/ofid/ofae178
Janice K. Louie
Rocio Agraz-Lara
Gustavo E. Velásquez
Open Forum Infectious Diseases
University of California, San Francisco
San Francisco Department of Public Health
Building similarity graph...
Analyzing shared references across papers
Loading...